Forte Biosciences Inc ( FBRX ) shares are trading lower by 17.9% to $19.03 Monday afternoon after the company announced it filed for an offer and resale from time to time of up to 9.5 million shares of common stock by selling stockholders.

What Else: This includes 4,931,389 outstanding shares and 4,615,555 shares issuable through the exercise of pre-funded warrants. These shares were issued via a private placement under a securities purchase agreement dated November 19, alongside a registration rights agreement.

Forte will cover registration expenses but will not receive proceeds from sales. The selling stockholders may sell shares publicly or privately at market prices, fixed prices or negotiated terms, bearing related sales expenses.

Read Also: Broadcom, Tesla Propel Nasdaq 100 Gains, Bitcoin Hits $107,000, Fuels Crypto Stocks Rally: What’s Driving Markets Monday?

Should I Sell My FBRX Stock?

When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.

Shares of Forte Biosciences ( FBRX ) have increased by 11.73% in the past year. An investor who bought shares of Forte Biosciences ( FBRX ) at the beginning of the year would take a loss of $0.75 per share if they sold it today. The stock has risen 227.33% over the past month, meaning an investor who bought shares on Nov. 1 would see a capital gain of $15.63.

Forte Biosciences ( FBRX ) shares have an all-time high of $57.25, representing 186.25% upside from current levels.

For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.

FBRX has a 52-week high of $28.68 and a 52-week low of $4.11.